Cardiovascular disease (CVD) is the number one cause of death worldwide, which propels
the development of advanced technologies for CVD diagnosis and treatment. Biomarker …

Gene therapy is a revolutionary treatment approach in the 21st century, offering significant
potential for disease prevention and treatment. However, the efficacy of gene delivery is …

Drug‐coated balloons (DCB) intervention is an important approach for the treatment of
atherosclerosis (AS). However, this therapeutic approach has the drawbacks of poor drug …

Aging is widespread worldwide and a significant risk factor for cardiovascular disease
(CVD). Mechanisms underlying aging have attracted considerable attention in recent years …

Precise diagnosis and treatment of tumors currently still face considerable challenges due to
the development of highly degreed heterogeneity in the dynamic evolution of tumors. With …

Pyroptosis, characterized by inflammasome activation, membrane Gasdermin D (GSDMD)‐
pore formulation, and the rapid release of inflammatory cytokines, can induce plaque …

Cardiovascular diseases (CVDs) are the primary drivers of the growing public health
epidemic and the leading cause of premature mortality and economic burden worldwide …

Nucleic acid nanostructures, derived from the assembly of nucleic acid building blocks (eg,
plasmids and oligonucleotides), are important intracellular carriers of therapeutic cargoes …

Spherical nucleic acids (SNAs) are three-dimensional and polyvalent nanostructures with
highly oriented and densely arranged nucleic acids shell attached to the surface of …

Atherosclerosis (AS) is a chronic inflammatory disease that is a major cause of
cardiovascular diseases (CVDs), including coronary artery disease, hypertension …